Results 31 to 40 of about 5,658 (197)
Gene therapy ameliorates neuromuscular pathology in CLN3 disease [PDF]
CLN3 disease is a neuronopathic lysosomal storage disorder that severely impacts the central nervous system (CNS) while also inducing notable peripheral neuromuscular symptoms.
Ewa A. Ziółkowska +14 more
doaj +2 more sources
Insights Into Aggregation-Delayed Phenotype of Dictyostelium discoideum. [PDF]
ABSTRACT Dictyostelium discoideum is a cellular model that has been widely used in cell signal research focusing on different cellular and developmental processes. The unique lifecycle of these cells—which involves switching between vegetative and development phases—makes Dictyostelium a reliable model for investigations in this field.
Alamer SA.
europepmc +2 more sources
CLN3 disease disrupts very early postnatal hippocampal maturation [PDF]
CLN3 disease or juvenile neuronal ceroid lipofuscinosis (Batten disease), is a progressive, severe, neurodegenerative, lysosomal storage disorder. Previous studies have demonstrated that network-level excitability differences are present in mouse models ...
Jeet B. Singh +8 more
doaj +2 more sources
A novel myopathy with autophagic vacuoles associated with biallelic variants in CLN8. [PDF]
We describe a novel adult‐onset myopathy with autophagic vacuoles and characteristic features of ceroid lipofuscinosis associated with biallelic CLN8 variants, seizures, and muscle weakness. Autophagosomal/lysosomal deposition of curvilinear, autofluorescent material containing the mitochondrial adenosine triphosphate (ATP) synthase membrane subunit c ...
Lindgren U +5 more
europepmc +2 more sources
Background Mutations in CLN3 cause Batten disease, however non‐syndromic CLN3 disease, characterized by retinal‐specific degeneration, has been also described.
Xiao Zhang +10 more
doaj +1 more source
A novel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3−/− cells [PDF]
Juvenile neuronal ceroid lipofuscinosis (JNCL) is a pediatric lysosomal storage disorder characterized by accumulation of autofluorescent storage material and neurodegeneration, which result from mutations in CLN3. The function of CLN3, a lysosomal membrane protein, is currently unknown.
Amanda L, Getty +2 more
openaire +2 more sources
Recognition and epileptology of protracted
AbstractObjectiveThis study was undertaken to analyze phenotypic features of a cohort of patients with protracted CLN3 disease to improve recognition of the disorder.MethodsWe analyzed phenotypic data of 10 patients from six families with protracted CLN3 disease.
Jillian M. Cameron +10 more
openaire +3 more sources
Identification of a Transactivation Motif in the CLN3 Protein [PDF]
AbstractA transactivation motif has been identified in the neurodegenerative disease protein, CLN3. The C‐terminal domain (residues 394‐438) of CLN3 can function as a transcriptional activator when fused to the DNA binding domain, LexA. A series of deletion and substitution constructs have been generated to identify the essential region for ...
K Y, Leung +3 more
openaire +2 more sources
Batten disease, one of the most devastating types of neurodegenerative lysosomal storage disorders, is caused by mutations in CLN3. Here, we show that CLN3 is a vesicular trafficking hub connecting the Golgi and lysosome compartments.
Alessia Calcagni’ +21 more
doaj +1 more source
Entry into the cell cycle occurs only when sufficient growth has occurred. In budding yeast, the cyclin Cln3 is thought to initiate cell cycle entry by inactivating a transcriptional repressor called Whi5.
Robert A Sommer +3 more
doaj +1 more source

